• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

T5O:GR

68.500 EUR 0.237 0.34%

As of 08:17:23 ET on 10/30/2014.

Snapshot for CytoTools AG (T5O)

Open: 68.300 Day's Range: 67.570 - 69.500 Volume: 610
Previous Close: 68.737 52wk Range: 25.105 - 76.343 1-Yr Rtn: +137.85%

Stock Chart for T5O

No chart data available.
  • T5O:GR 68.500
  • 1D
  • 1M
  • 1Y
68.737
Interactive T5O Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for T5O

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.4295
Est. EPS (EUR) (12/2014) -0.8500
Est. PEG Ratio -
Market Cap (M EUR) 129.79
Shares Outstanding (M) 1.90
30 Day Average Volume 5,614
Price/Book (mrq) 15.9774
Price/Sale (ttm) 325.2398
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for T5O

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for T5O

Cytotools AG is a biotechnology company that discovers and develops small molecules and biologics for the treatment of chronic wounds, vascular diseases and cancer.

Mark-Andre FreybergChairman-Mgmt BoardDirk KaiserMember-Mgmt Board
Markus Hugo WeissbachChief Medical Officer
More Company Profile & Key Executives for T5O

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil